Skandinaviska Enskilda Banken Ab (Publ) Legend Biotech Corp Transaction History
Skandinaviska Enskilda Banken Ab (Publ)
- $21.5 Billion
- Q3 2024
A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Legend Biotech Corp stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 12,300 shares of LEGN stock, worth $444,030. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,300
Previous 12,300
-0.0%
Holding current value
$444,030
Previous $544,000
10.11%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding LEGN
# of Institutions
227Shares Held
74.5MCall Options Held
279KPut Options Held
350K-
Price T Rowe Associates Inc Baltimore, MD11.2MShares$403 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$271 Million5.1% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$240 Million7.41% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$207 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.04MShares$182 Million1.16% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.04B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...